TLR4 and experimental autoimmune encephalomyelitis: reported that blocking TLR2/TLR4 in the experimental autoimmune encephalomyelitis (EAE) model of multiple sclerosis prevents the production of proinflammatory factors, which is consistent with our clinical data (26).